ArticleFrontiers in endocrinology2026
Clinical and aesthetic outcomes of transumbilical single-port versus multi-port laparoscopic ovarian cystectomy.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Ovarian cysts often require surgery. This study compared clinical outcomes and aesthetic satisfaction between transumbilical single-port (SP-LC)s and traditional multi-port laparoscopic cystectomy (MPL). Methods: A retrospective analysis was conducted on patients undergoing laparoscopic ovarian cystectomy from October 2023 to September 2025. Patients were divided into MPL and SP-LC groups based on surgical technique. Perioperative parameters were recorded. Postoperative pain was assessed using the Visual Analog Scale (VAS) at 24 and 72 hours. Inflammatory markers were measured preoperatively and 24 hours postoperatively. Ovarian reserve function was evaluated preoperatively and at 1 and 3 months postoperatively. Postoperative complications were documented. Aesthetic satisfaction was assessed at discharge, and scar quality was evaluated using the Patient Scar Assessment Scale (PSAS)ss at 1 and 3 months postoperatively. Results: SP-LC showed better perioperative recovery than MPL. It was associated with less intraoperative blood loss (43.06 ± 11.79 vs. 48.12 ± 12.85 mL, P = 0.014), earlier first exhaust (15.82 ± 5.21 vs. 18.47 ± 5.74 h, P = 0.004), earlier ambulation (13.89 ± 3.17 vs. 15.63 ± 3.51 h, P = 0.002), and shorter hospital stay (3.94 ± 0.85 vs. 4.31 ± 0.92 d, P = 0.011). Pain scores were lower in the SP-LC group at 24 and 72 hours postoperatively (both P<0.001). Postoperative CRP and WBC levels were also lower after SP-LC (both P<0.001). Ovarian reserve markers did not differ significantly between groups. The overall complication rate was lower in the SP-LC group (11.59% vs. 25.93%, P = 0.027). Aesthetic satisfaction at discharge was higher after SP-LC (P = 0.006), and PSAS scores were lower at 1 and 3 months postoperatively (P = 0.002 and P = 0.003). Conclusion: Transumbilical single-port laparoscopic ovarian cystectomy is associated with faster recovery, reduced inflammation, fewer complications, and superior aesthetics without compromising ovarian reserve.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.